Pay in 4 interest-free payments of $5.76 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
BPC-157 holds fifteen amino acids arranged in a stable shape
The study noted that injectable forms promoted more strong angiogenesis and collagen deposition
FOXO4-DRI is studied within the senolytic compound class alongside navitoclax and quercetin analogs, with researchers using it as a peptide-based mechanistic comparator targeting the FOXO4-p53 axis specifically
This compound is not approved by the FDA or any regulatory authority and is intended solely for laboratory research purposes
US$ 23.27
US$ 27.82
US$ 28.69
US$ 23.00
